Logo.png
Global Gummy Vitamins Market to Witness Upsurge in Growth by 2030, Assesses DelveInsight | Key Companies - Otsuka, Bayer, Pfizer, Abbott, Bionova, International Flavors & Fragrances, NOW Foods
11 avr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, April 11, 2024 (GLOBE NEWSWIRE) -- Global Gummy Vitamins Market to Witness Upsurge in Growth by 2030, Assesses DelveInsight | Key Companies - Otsuka, Bayer, Pfizer, Abbott, Bionova,...
Logo.png
Global Dietary Supplements Market to Grow Immensely by 2030, Predicts DelveInsight | Key Companies - Amway, Abbott, Bayer, Pfizer, Otsuka, GlaxoSmithKline, American Health, Good Health New Zealand
10 avr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, April 10, 2024 (GLOBE NEWSWIRE) -- Global Dietary Supplements Market to Grow Immensely by 2030, Predicts DelveInsight | Key Companies - Amway, Abbott, Bayer, Pfizer, Otsuka,...
Logo.png
Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies - Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma
09 avr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, April 09, 2024 (GLOBE NEWSWIRE) -- Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies - Idorsia, Janssen...
Logo.png
TROP-2 Inhibitors Market to Boost by 2034, Predicts DelveInsight | Key Companies to Look Out - Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics
09 avr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, April 09, 2024 (GLOBE NEWSWIRE) -- TROP-2 Inhibitors Market to Boost by 2034, Predicts DelveInsight | Key Companies to Look Out - Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck,...
Logo.png
Excessive Daytime Sleepiness Market is Projected to Boost at a Moderate Growth Rate by 2032, Predicts DelveInsight | Key Companies in the Market - Avadel Pharmaceutical, Axsome Therapeutic, Theranexus, XWPharma, Takeda Pharmaceutical
09 avr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, April 09, 2024 (GLOBE NEWSWIRE) -- Excessive Daytime Sleepiness Market is Projected to Boost at a Moderate Growth Rate by 2032, Predicts DelveInsight | Key Companies in the Market -...
Logo.png
Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran
27 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 27, 2024 (GLOBE NEWSWIRE) -- Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009,...
Logo.png
Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis, Alladapt Immunotherapeutics, Regeneron Pharmaceuticals, Genentech, Parexel
26 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 26, 2024 (GLOBE NEWSWIRE) -- Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis,...
Logo.png
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
25 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 25, 2024 (GLOBE NEWSWIRE) -- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The rise in the number of people suffering from cirrhosis can be...
Logo.png
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain
21 mars 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, March 21, 2024 (GLOBE NEWSWIRE) -- PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the...
Logo.png
Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion, Zambon SpA, Mallinckrodt, Incyte Corporation, GlaxoSmithKline, Mereo Biopharma, Genentech
29 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion,...